An Inflammatory Skin Reaction After Cetuximab Treatment for Aggressive Cutaneous Squamous Cell Carcinoma in a Heart Transplant Patient Previously Taking Voriconazole
- PMID: 26720404
- DOI: 10.1001/jamadermatol.2015.4529
An Inflammatory Skin Reaction After Cetuximab Treatment for Aggressive Cutaneous Squamous Cell Carcinoma in a Heart Transplant Patient Previously Taking Voriconazole
Similar articles
-
Efficacy and Tolerance of Cetuximab Alone or Combined with Chemotherapy in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: An Open Study of 14 Patients.Dermatology. 2016;232(6):721-730. doi: 10.1159/000461578. Epub 2017 Apr 7. Dermatology. 2016. PMID: 28384639
-
Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck.Int J Dermatol. 2017 Jun;56(6):602-609. doi: 10.1111/ijd.13507. Epub 2017 Mar 1. Int J Dermatol. 2017. PMID: 28247918 Review.
-
Response of Cutaneous Squamous Cell Carcinoma to Treatment With Cetuximab.Dermatol Surg. 2019 Feb;45(2):313-316. doi: 10.1097/DSS.0000000000001583. Dermatol Surg. 2019. PMID: 29957662 No abstract available.
-
Complete Remission of Squamous Cell Carcinoma After Treatment With Panitumumab in a Patient With Cetuximab-Induced Anaphylaxis.JAMA Dermatol. 2016 Mar;152(3):343-5. doi: 10.1001/jamadermatol.2015.4134. JAMA Dermatol. 2016. PMID: 26606112 No abstract available.
-
High-risk cutaneous squamous cell carcinoma in a Japanese allogeneic bone marrow transplant recipient on long-term voriconazole.J Dermatol. 2017 Oct;44(10):1152-1155. doi: 10.1111/1346-8138.13867. Epub 2017 May 4. J Dermatol. 2017. PMID: 28470790 Review.
Cited by
-
Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents.Drugs. 2019 Jun;79(8):833-853. doi: 10.1007/s40265-019-01127-8. Drugs. 2019. PMID: 31093949 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical